Conversely, in the aldesleukin-, αPD-L1 × non-α IL-2v-, and MB2033-treated groups, the clump size increased along with an increase in caspase 3/7+ intensity within the clumps, allowing for efficient tumor cell killing. The gene discussed is CASP3; the disease is neoplasm.